Kathleen P. Gallagher's most recent trade in Avidity Biosciences Inc was a trade of 911 Common Stock done at an average price of $30.2 . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 30.24 per share. | 17 Jun 2025 | 911 | 50,392 | - | 30.2 | 27,549 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. | 02 Jun 2025 | 5,875 | 56,429 | - | 16.7 | 97,819 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 32.48 per share. | 02 Jun 2025 | 5,875 | 50,554 | - | 32.5 | 190,833 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 5,875 | 22,596 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Kathleen Gallagher P. | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 5,875 | 28,471 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | P. Gallagher Kathleen | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. | 01 May 2025 | 5,875 | 56,429 | - | 16.7 | 97,819 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 32.40 per share. | 01 May 2025 | 5,875 | 50,554 | - | 32.4 | 190,324 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share. | 01 Apr 2025 | 5,546 | 56,100 | - | 14.7 | 81,526 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 5,546 | 13,829 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 27.83 per share. | 01 Apr 2025 | 5,546 | 50,554 | - | 27.8 | 154,331 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 27.83 per share. | 01 Apr 2025 | 329 | 50,554 | - | 27.8 | 9,155 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 329 | 34,346 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. | 01 Apr 2025 | 329 | 50,883 | - | 16.7 | 5,478 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,875 | 19,375 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 29.41 per share. | 03 Mar 2025 | 5,875 | 50,554 | - | 29.4 | 172,807 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share. | 03 Mar 2025 | 5,875 | 56,429 | - | 14.7 | 86,363 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.65 per share. | 03 Feb 2025 | 5,875 | 56,429 | - | 16.7 | 97,819 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 5,875 | 34,675 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 32.16 per share. | 03 Feb 2025 | 5,875 | 50,554 | - | 32.2 | 188,918 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 30.16 per share. | 21 Jan 2025 | 5,629 | 50,554 | - | 30.2 | 169,776 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 21 Jan 2025 | 1,817 | 56,183 | - | 28.6 | 51,953 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 21 Jan 2025 | 1,295 | 58,670 | - | 28.6 | 37,024 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 21 Jan 2025 | 670 | 58,000 | - | 28.6 | 19,159 | Common Stock |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Kathleen P. Gallagher | Chief Program Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 59,965 | - | 0 | Common Stock |